A Novel Technique for Individualized Treatment of Breast Cancer during Diagnostic Biopsy to Determine its Potential for Treatment with Glucosodiene

Authors: Maher M. Akl* and Amr Kamel Ahmed

DOI: 10.23880/cclsj-16000186

Volume 8, Issue 2

Abstract

Breast cancer remains a significant challenge in the field of oncology, particularly the aggressive triple-negative breast cancer (TNBC) subtype, accounting for 15-20% of cases. TNBC lacks estrogen, progesterone, and HER2 receptors, making it difficult to target with conventional therapies. In light of this, there is an urgent need to explore novel treatment approaches that can effectively address the unique characteristics of TNBC [1].

Keywords: Breast Cancer; Glucosodiene; Biopsy

View PDF